Utilizing Vision Transformers for Predicting Early Response of Brain Metastasis to Magnetic Resonance Imaging-Guided Stage Gamma Knife Radiosurgery Treatment.

BACKGROUND/

objectivesThis study explores the application of vision transformers to predict early responses to stereotactic radiosurgery in patients with brain metastases using minimally pre-processed magnetic resonance imaging scans. The objective is to assess the potential of vision transformers as a predictive tool for clinical decision-making, particularly in the context of imbalanced datasets.

methodsWe analyzed magnetic resonance imaging scans from 19 brain metastases patients, focusing on axial fluid-attenuated inversion recovery and high-resolution contrast-enhanced T1-weighted sequences. Patients were categorized into responders (complete or partial response) and non-responders (stable or progressive disease).

resultsDespite the imbalanced nature of the dataset, our results demonstrate that vision transformers can predict early treatment responses with an overall accuracy of 99%. The model exhibited high precision (99% for progression and 100% for regression) and recall (99% for progression and 100% for regression). The use of the attention mechanism in the vision transformers allowed the model to focus on relevant features in the magnetic resonance imaging images, ensuring an unbiased performance even with the imbalanced data. Confusion matrix analysis further confirmed the model's reliability, with minimal misclassifications. Additionally, the model achieved a perfect area under the receiver operator characteristic curve (AUC = 1.00), effectively distinguishing between responders and non-responders.

conclusionsThese findings highlight the potential of vision transformers, aided by the attention mechanism, as a non-invasive, predictive tool for early response assessment in clinical oncology. The vision transformer (ViT) model employed in this study processes MRIs as sequences of patches, enabling the capture of localized tumor features critical for early response prediction. By leveraging patch-based feature learning, this approach enhances robustness, interpretability, and clinical applicability, addressing key challenges in tumor progression prediction following stereotactic radiosurgery (SRS). The model's robust performance, despite the dataset imbalance, underscores its ability to provide unbiased predictions. This approach could significantly enhance clinical decision-making and support personalized treatment strategies for brain metastases. Future research should validate these findings in larger, more diverse cohorts and explore the integration of additional data types to further optimize the model's clinical utility.